KEGG   DRUG: Itolizumab
Entry
D12426                      Drug                                   
Name
Itolizumab (USAN/INN)
Formula
C6440H10020N1714O2023S44
Exact mass
145144.1591
Mol weight
145233.68
Sequence
(Heavy chain)
EVQLVESGGG LVKPGGSLKL SCAASGFKFS RYAMSWVRQA PGKRLEWVAT ISSGGSYIYY
PDSVKGRFTI SRDNVKNTLY LQMSSLRSED TAMYYCARRD YDLDYFDSWG QGTLVTVSSA
STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCKASRDIR SYLTWYQQKP GKAPKTLIYY ATSLADGVPS
RFSGSGSGQD YSLTISSLES DDTATYYCLQ HGESPFTLGS GTKLEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Immunomodulator
  Type
Monoclonal antibody
Comment
Treatment of autoimmune and inflammatory diseases
Target
CD6 (TP120) [HSA:923] [KO:K06456]
  Pathway
hsa04514  Cell adhesion molecules
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD6 (TP120)
     D12426  Itolizumab (USAN/INN)
Other DBs
CAS: 1116433-11-4
PubChem: 497620839
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system